CS269989B2 - Method of 3-(4-cyano-4-phenylalkyl)tetrahydroisoquinoline derivatives production - Google Patents

Method of 3-(4-cyano-4-phenylalkyl)tetrahydroisoquinoline derivatives production Download PDF

Info

Publication number
CS269989B2
CS269989B2 CS868817A CS881786A CS269989B2 CS 269989 B2 CS269989 B2 CS 269989B2 CS 868817 A CS868817 A CS 868817A CS 881786 A CS881786 A CS 881786A CS 269989 B2 CS269989 B2 CS 269989B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
compound
dimethoxyphenyl
acid
isopropyl
Prior art date
Application number
CS868817A
Other languages
Czech (cs)
English (en)
Other versions
CS881786A2 (en
Inventor
Robin D Clark
Joseph M Muchowski
Fang-Ting Chiu
John O Gardner
Jacob Berger
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of CS881786A2 publication Critical patent/CS881786A2/cs
Publication of CS269989B2 publication Critical patent/CS269989B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS868817A 1985-12-02 1986-12-01 Method of 3-(4-cyano-4-phenylalkyl)tetrahydroisoquinoline derivatives production CS269989B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/803,464 US4613606A (en) 1985-12-02 1985-12-02 Tetrahydroisoquinoline derivatives

Publications (2)

Publication Number Publication Date
CS881786A2 CS881786A2 (en) 1989-09-12
CS269989B2 true CS269989B2 (en) 1990-05-14

Family

ID=25186568

Family Applications (1)

Application Number Title Priority Date Filing Date
CS868817A CS269989B2 (en) 1985-12-02 1986-12-01 Method of 3-(4-cyano-4-phenylalkyl)tetrahydroisoquinoline derivatives production

Country Status (5)

Country Link
US (1) US4613606A (ja)
JP (1) JPS62155247A (ja)
CS (1) CS269989B2 (ja)
SU (2) SU1598875A3 (ja)
ZA (1) ZA869059B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4667038A (en) * 1985-12-02 1987-05-19 Syntex (U.S.A.) Inc. Tetrahydroisoquinoline derivatives
US4978793A (en) * 1988-06-23 1990-12-18 W. R. Grace & Co.-Conn. Novel process for the preparation of serinol
US5135944A (en) * 1989-06-21 1992-08-04 Syntex (U.S.A.) Inc. Bis(benzylpyrrolidine) derivatives useful for treating congestive heart failure and acute renal failure
US5100912A (en) * 1990-05-14 1992-03-31 Syntex (U.S.A.) Inc. Bis(benzylpyrrolidine) derivatives as dopamine agonists
US5093355A (en) * 1989-10-30 1992-03-03 Syntex (U.S.A.) Inc. Benzylpyrrolidine derivatives as dopamine agonists
CA2061260A1 (en) * 1991-02-27 1992-08-28 Kiyofumi Ishikawa Isoquinoline derivatives
US5362736A (en) * 1991-02-27 1994-11-08 Banyu Pharmaceutical Co., Ltd. Isoquinoline derivatives
DE19719817A1 (de) * 1997-05-13 1998-11-19 Hoechst Ag Substituierte 6- und 7-Aminotetrahydroisochinolincarbonsäuren
AU2002211621A1 (en) 2000-10-10 2002-04-22 Calyx Therapeutics, Inc. Tricyclic compounds and uses thereof
US8440695B2 (en) * 2005-11-09 2013-05-14 St Jude Children's Research Hospital Use of chloroquine to treat metabolic syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1802804A1 (de) * 1968-10-12 1970-06-11 Knoll Ag 1-[3'-Cyan-3'-(2'',3''-dimethoxyphenyl)-4'-methylpentyl]-2-methyl-6,7-dimethoxy-1,2,3,4-Tetrahydroisochinolin
DE2854210C2 (de) * 1978-12-15 1984-08-09 Degussa Ag, 6000 Frankfurt Verfahren zur Herstellung von aromatisch oder heteroaromatisch substituierten Acetonitrilen

Also Published As

Publication number Publication date
US4613606A (en) 1986-09-23
SU1591806A3 (ru) 1990-09-07
ZA869059B (en) 1988-07-27
JPS62155247A (ja) 1987-07-10
CS881786A2 (en) 1989-09-12
SU1598875A3 (ru) 1990-10-07

Similar Documents

Publication Publication Date Title
EP0389352B1 (fr) Dérivés fluoro-4 benzoiques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
KR860001761B1 (ko) 광학활성 카바졸 유도체의 제조방법
EP0302788B1 (fr) Dérivés de [(pipéridinyl-4)méthyl]-2 tétrahydro-1,2,3,4 9H-pyrido[3,4-b]indole, leur préparation et leur application en thérapeutique
TWI840423B (zh) 甲狀腺素受體β促效劑化合物
JPH0739387B2 (ja) 新規1−ベンジル−アミノアルキル−ピロリジノン化合物及びその製造方法
SK120694A3 (en) Indole derivatives as 5-ht1 agonists
CS269989B2 (en) Method of 3-(4-cyano-4-phenylalkyl)tetrahydroisoquinoline derivatives production
CS207666B2 (en) Method of making the 2-bromergosin and the additive salts thereof with the acid
SK46793A3 (en) Regenarative melting tank and method of working
EP0351255B1 (fr) Dérivés de [(pipéridinyl-4)méthyl]-2 tétrahydro-1,2,3,4 isoquinoléine, leur préparation et leur application en thérapeutique
US5026863A (en) 1,4-dihydropyridine compounds
NZ195329A (en) 6,7-benzomorphan derivatives and pharmaceutical compositions
NZ208896A (en) Benzazepine and benzoxazepine derivatives and pharmaceutical compositions
US5693640A (en) Pyridazino-indole derivatives
US3499906A (en) 5,9-diethyl-2'-hydroxy-2-substituted-6,7-benzomorphans
HU176231B (en) Process for producing 4a-aryl-octahydro-1h-2-pyridine derivatives
EP0074711B1 (en) Benzodioxane-imidazoline compounds, their preparation and use
HU197312B (en) Process for producing tetrahydroisoquinoline derivatives and pharmaceuticals comprising such active ingredient
AP899A (en) Indole derivatives useful in therapy.
US4810712A (en) Bicyclic lactams, processes for their use, and formulations containing these compounds
WO2001000619A1 (fr) Nouveaux derives benzodioxanne imidazolines fluores, leur preparation et leurs applications en therapeutique
EP0136198A1 (fr) Dérivés de triazolo pyrimidine, leur procédé de préparation et leur application thérapeutique en tant que toni-cardiaques
KR840000033B1 (ko) 이소퀴놀린 유도체의 제조방법
JP4117462B2 (ja) ナフチリジンおよびキノリン誘導体
KR810000583B1 (ko) 4a-아릴-옥타하이드로-1H-2-피린딘류의 제조방법